Trial Frees Type 1 Diabetes Patients From Daily Insulin Jabs
A groundbreaking clinical trial using islet cell transplants and Tegoprubart freed five Type 1 diabetes patients from daily insulin jabs, marking a huge step toward a functional cure.
News That Embraces Insight and Understanding
A groundbreaking clinical trial using islet cell transplants and Tegoprubart freed five Type 1 diabetes patients from daily insulin jabs, marking a huge step toward a functional cure.